Search This Blog

Friday, August 10, 2018

Gilead Sciences (GILD) Remains a Buy at Mizuho Securities


Mizuho Securities analyst Salim Syed maintained a Buy rating on Gilead Sciences (NASDAQ: GILD) today and set a price target of $94.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.